{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:47:43Z","timestamp":1792799263931,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s42000-021-00326-x","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T21:11:53Z","timestamp":1634159513000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improving management of severe hypoparathyroidism: a case series"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-3516","authenticated-orcid":false,"given":"Beatriz","family":"Ugalde-Abiega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lamas Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Joaqu\u00edn","family":"Alfaro Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalla","family":"Meizoso-Pita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sevillano Collantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Gomez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Perez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"326_CR1","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1089\/thy.2017.0309","volume":"28","author":"LA Orloff","year":"2018","unstructured":"Orloff LA, Wiseman SM, Bernet VJ, Fahey TJ, Shaha AR, Shindo ML, Snyder SK, Stack BC, Sunwoo JB, Wang MB, for the American Thyroid Association Surgical Affairs Committee Writing Task Force, (2018) American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid 28:830\u2013841. https:\/\/doi.org\/10.1089\/thy.2017.0309","journal-title":"Thyroid"},{"key":"326_CR2","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT (2016) Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 101:2273\u20132283. https:\/\/doi.org\/10.1210\/jc.2015-3907","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s002689900459","volume":"22","author":"F Pattou","year":"1998","unstructured":"Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau J-L, Racadot A, Proye C (1998) Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J of Surg 22:718\u2013724. https:\/\/doi.org\/10.1007\/s002689900459","journal-title":"World J of Surg"},{"key":"326_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.endonu.2012.11.002","volume":"60","author":"\u00c1 Larrad Jim\u00e9nez","year":"2013","unstructured":"Larrad Jim\u00e9nez \u00c1, Hern\u00e1ndez Hern\u00e1ndez JR (2013) Autotrasplante de paratiroides Endocrinol Nut 60:161\u2013163. https:\/\/doi.org\/10.1016\/j.endonu.2012.11.002","journal-title":"Autotrasplante de paratiroides Endocrinol Nut"},{"key":"326_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/0300060518794840","volume":"47","author":"L Du","year":"2019","unstructured":"Du L, Zhang X, Yan L, Zhang H, Tang X, Kong X, Liu G, Huang J (2019) A practical self-made device in parathyroid autotransplantation for patients with secondary hyperparathyroidism. J Int Med Res 47:59\u201365. https:\/\/doi.org\/10.1177\/0300060518794840","journal-title":"J Int Med Res"},{"key":"326_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6065720","volume":"2018","author":"C Casella","year":"2018","unstructured":"Casella C, Galani A, Totaro L, Ministrini S, Lai S, Dimko M, Portolani N (2018) Total parathyroidectomy with subcutaneous parathyroid forearm autotransplantation in the treatment of secondary hyperparathyroidism: a single-center experience. Int J Endocrinol 2018:1\u20137. https:\/\/doi.org\/10.1155\/2018\/6065720","journal-title":"Int J Endocrinol"},{"key":"326_CR7","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT, Brandi ML, Clarke BL, Shoback D, J\u00fcppner H, D\u2019Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26:2317\u20132337. https:\/\/doi.org\/10.1002\/jbmr.483","journal-title":"J Bone Miner Res"},{"key":"326_CR8","first-page":"395","volume":"63","author":"JP Collip","year":"1925","unstructured":"Collip JP (1925) The extraction of parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium 63:395\u2013438","journal-title":"The extraction of parathyroid hormone which will prevent or control parathyroid tetany and which regulates the level of blood calcium"},{"key":"326_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","volume":"36","author":"BL Clarke","year":"2014","unstructured":"Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H (2014) Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1\u201384) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clin Ther 36:722\u2013736. https:\/\/doi.org\/10.1016\/j.clinthera.2014.04.001","journal-title":"Clin Ther"},{"key":"326_CR10","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1080\/14712598.2016.1238455","volume":"16","author":"G Marcucci","year":"2016","unstructured":"Marcucci G, Della Pepa G, Brandi ML (2016) Natpara for the treatment of hypoparathyroidism. Expert Opin Biol Ther 16:1417\u20131424. https:\/\/doi.org\/10.1080\/14712598.2016.1238455","journal-title":"Expert Opin Biol Ther"},{"key":"326_CR11","first-page":"322","volume":"152","author":"LE Guti\u00e9rrez-Cerecedo","year":"2016","unstructured":"Guti\u00e9rrez-Cerecedo LE, Vergara-L\u00f3pez A, Rosas-Barrientos JV, Guill\u00e9n-Gonz\u00e1lez M\u00c1 (2016) Reduction in requirements of oral calcium and 1\u201325 dihydroxy vitamin D in patients with post-surgical hypoparathyroidism treated with teriparatide (PTH1-34). Gac Med Mex 152:322\u2013328","journal-title":"Gac Med Mex"},{"key":"326_CR12","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1210\/jc.2019-00893","volume":"104","author":"Y-KD Tay","year":"2019","unstructured":"Tay Y-KD, Tabacco G, Cusano NE, Williams J, Omeragic B, Majeed R, Gomez Almonte M, Bilezikian JP, Rubin MR (2019) Therapy of hypoparathyroidism with rhPTH(1\u201384): a prospective, 8-year investigation of efficacy and safety. J Clin Endocrinol Metab 104:5601\u20135610. https:\/\/doi.org\/10.1210\/jc.2019-00893","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR13","doi-asserted-by":"publisher","first-page":"e3557","DOI":"10.1210\/clinem\/dgaa490","volume":"105","author":"KS Chen","year":"2020","unstructured":"Chen KS, Gosmanova EO, Curhan GC, Ketteler M, Rubin M, Swallow E, Zhao J, Wang J, Sherry N, Krasner A, Bilezikian JP (2020) Five-year estimated glomerular filtration rate in patients with hypoparathyroidism treated with and without rhPTH(1\u201384). J Clin Endocrinol Metab 105:e3557\u2013e3565. https:\/\/doi.org\/10.1210\/clinem\/dgaa490","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1210\/jc.2012-2984","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Rubin MR, McMahon DJ, Zhang C, Ives R, Tulley A, Sliney J, Cremers SC, Bilezikian JP (2013) Therapy of hypoparathyroidism with PTH(1\u201384): a prospective four-year investigation of efficacy and safety. J Clin Endocrinol Metab 98:137\u2013144. https:\/\/doi.org\/10.1210\/jc.2012-2984","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR15","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1210\/jcem.83.10.5185","volume":"83","author":"KK Winer","year":"1998","unstructured":"Winer KK, Yanovski JA, Sarani B, Cutler GB Jr (1998) A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83:3480\u20133486. https:\/\/doi.org\/10.1210\/jcem.83.10.5185","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR16","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-2552","volume":"93","author":"KK Winer","year":"2008","unstructured":"Winer KK, Sinaii N, Peterson D, Sainz B, Cutler GB (2008) Effects of once versus twice-daily parathyroid hormone 1\u201334 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93:3389\u20133395. https:\/\/doi.org\/10.1210\/jc.2007-2552","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/jc.2011-1908","volume":"97","author":"KK Winer","year":"2012","unstructured":"Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS, Cutler GB (2012) Synthetic human parathyroid hormone 1\u201334 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab 97:391\u2013399. https:\/\/doi.org\/10.1210\/jc.2011-1908","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/s-2007-967088","volume":"115","author":"N Angelopoulos","year":"2007","unstructured":"Angelopoulos N, Goula A, Tolis G (2007) Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review. Exp Clin Endocrinol Diabetes 115:50\u201354. https:\/\/doi.org\/10.1055\/s-2007-967088","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1\u20132","key":"326_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1515\/jpem-2013-0159","volume":"27","author":"P Matarazzo","year":"2014","unstructured":"Matarazzo P, Tuli G, Fiore L, Mussa A, Feyles F, Peiretti V, Lala R (2014) Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism. J Pediat Endocrinol Metab 27(1\u20132):53\u201359. https:\/\/doi.org\/10.1515\/jpem-2013-0159","journal-title":"J Pediat Endocrinol Metab"},{"key":"326_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/ctr.12622","volume":"29","author":"T Hod","year":"2015","unstructured":"Hod T, Riella LV, Chandraker A (2015) Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report. Clin Transplant 29:951\u2013957. https:\/\/doi.org\/10.1111\/ctr.12622","journal-title":"Clin Transplant"},{"key":"326_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000479867","volume":"89","author":"V Saraff","year":"2018","unstructured":"Saraff V, Rothenbuhler A, H\u00f6gler W, Linglart A (2018) Continuous subcutaneous recombinant parathyroid hormone (1\u201334) infusion in the management of childhood hypoparathyroidism associated with malabsorption. Horm Res Paediatr 89:271\u2013277. https:\/\/doi.org\/10.1159\/000479867","journal-title":"Horm Res Paediatr"},{"key":"326_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.endonu.2015.03.006","volume":"62","author":"AO A\u00f1\u00f3n","year":"2015","unstructured":"A\u00f1\u00f3n AO, Porta MM, L\u00f3pez CQ, Hanzu FA, Rabinovich IH (2015) Treatment of unresponsive hypoparathyroidism when the oral route administration is not possible: considering subcutaneous teriparatide. Endocrinol Nut 62:361\u2013362. https:\/\/doi.org\/10.1016\/j.endonu.2015.03.006","journal-title":"Endocrinol Nut"},{"key":"326_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jamaoto.2015.1497","volume":"141","author":"M Shah","year":"2015","unstructured":"Shah M, Bancos I, Thompson GB, Richards ML, Kasperbauer JL, Clarke BL, Drake MT, Stan MN (2015) Teriparatide therapy and reduced postoperative hospitalization for postsurgical hypoparathyroidism. JAMA Otolaryngol Head Neck Surg 141:822\u2013827. https:\/\/doi.org\/10.1001\/jamaoto.2015.1497","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"326_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/ckj\/sfv005","volume":"8","author":"P Giamalis","year":"2015","unstructured":"Giamalis P, Economidou D, Dimitriadis C, Memmos D, Papagianni A, Efstratiadis G (2015) Treatment of adynamic bone disease in a haemodialysis patient with teriparatide. Clin Kidney J 8:188\u2013190. https:\/\/doi.org\/10.1093\/ckj\/sfv005","journal-title":"Clin Kidney J"},{"key":"326_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1053\/j.ajkd.2015.01.025","volume":"65","author":"P Palcu","year":"2015","unstructured":"Palcu P, Dion N, Ste-Marie L-G, Goltzman D, Radziunas I, Miller PD, Jamal SA (2015) Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report. Am J Kidney Dis 65:933\u2013936. https:\/\/doi.org\/10.1053\/j.ajkd.2015.01.025","journal-title":"Am J Kidney Dis"},{"key":"326_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12020-019-02128-z","volume":"67","author":"G Tuli","year":"2020","unstructured":"Tuli G, Buganza R, Tessaris D, Einaudi S, Matarazzo P, de Sanctis L (2020) Teriparatide (rhPTH 1\u201334) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism. Endocrine 67:457\u2013465. https:\/\/doi.org\/10.1007\/s12020-019-02128-z","journal-title":"Endocrine"},{"key":"326_CR27","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/jbmr.3824","volume":"34","author":"L Holten-Andersen","year":"2019","unstructured":"Holten-Andersen L, Pihl S, Rasmussen CE, Zettler J, Maitro G, Baron J, Heinig S, Hoffmann E, Wegge T, Krusch M, Faltinger F, Killian S, Sprogoe K, Karpf DB, Breinholt VM, Cleemann F (2019) Design and preclinical development of TransCon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism. J Bone Miner Res 34:2075\u20132086. https:\/\/doi.org\/10.1002\/jbmr.3824","journal-title":"J Bone Miner Res"},{"key":"326_CR28","doi-asserted-by":"publisher","first-page":"SAT-LB72","DOI":"10.1210\/jendso\/bvaa046.2209","volume":"4","author":"AA Khan","year":"2020","unstructured":"Khan AA, Rejnmark L, Schwarz PE, Vokes TJ, Clarke BL, Rubin MR, Hofbauer LC, Erikson E, Palermo A, Pagotto U, Marcocci C, Ahmed I, Mourya S, Markova D, Karpf DB (2020) SAT-LB72 design of the PaTH Forward Phase 2 trial of TransCon PTH, a long-acting PTH, in patients with hypoparathyroidism. J Clin Endocrinol Metab 4:SAT-LB72. https:\/\/doi.org\/10.1210\/jendso\/bvaa046.2209","journal-title":"J Clin Endocrinol Metab"},{"key":"326_CR29","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0366","author":"G Zavatta","year":"2020","unstructured":"Zavatta G, Clarke BL (2020) Challenges in the management of chronic hypoparathyroidism. Endocr Connect. https:\/\/doi.org\/10.1530\/EC-20-0366","journal-title":"Endocr Connect"}],"updated-by":[{"DOI":"10.1007\/s42000-021-00338-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00326-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T14:09:16Z","timestamp":1644242956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00326-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00326-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s42000-021-00338-7","asserted-by":"object"}]},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s42000-021-00338-7","URL":"https:\/\/doi.org\/10.1007\/s42000-021-00338-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Informed consent to publish was obtained from participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}